Table 2.

Gastric cancer, intestinal metaplasia, and neutrophil infiltration in propensity score–matched patients with aspirin

Aspirin useNonuse
n = 2,082 (%)n = 2,082 (%)P
Gastric cancer17 (0.82)8 (0.38)0.071
 Diffuse-type1 (0.05)5 (0.24)0.218
 Intestinal-type16 (0.77)3 (0.14)0.004
Intestinal metaplasiaa,b628 (40.44)615 (41.61)0.512
 Antrum524 (33.63)529 (35.70)0.232
 Corpus248 (15.69)219 (14.80)0.494
Neutrophil infiltrationa,b770 (49.71)733 (49.86)0.932
 Antrum540 (34.82)532 (36.02)0.489
 Corpus675 (42.94)636 (43.12)0.920
  • NOTE: Bold indicates statistical significance (P < 0.05).

  • aAllows duplicated.

  • bIncludes missing data.